#31 of pharma imports · Intermediates & KSMs
Beta picoline (3-methylpyridine): imports into India
Tariff line 29333916 · CAS 108-99-6
Imports 2025-26
3,745 t
-9.6% vs 2024-25
Import bill (CIF, before duty)
₹109 cr
Volume growth, 2020-21 to 2025-26
-5.5% a year
Falling
Net imports 2025-26
2,665 t
Exports 1,080 t
Import volume by financial year
FallingShow as table
| Year | Imports | Import bill |
|---|---|---|
| 2020-21 | 4,959 t | ₹140 cr |
| 2021-22 | 4,716 t | ₹167 cr |
| 2022-23 | 6,018 t | ₹173 cr |
| 2023-24 | 4,013 t | ₹109 cr |
| 2024-25 | 4,144 t | ₹130 cr |
| 2025-26 | 3,745 t | ₹109 cr |
Where it comes from (2025-26)
Share of the import bill
- China76.5%
- USA19.4%
- Italy4%
What's changing
- Jubilant Ingrevia, India's largest pyridine and picoline maker, said it kept its global leadership and market share in beta-picoline in Q1 FY26 and runs these plants at about 80% utilisation.Jubilant Ingrevia earnings call, 31 Jul 2025
Reported facts with their source. Not a forecast.
Buy or supply beta picoline (3-methylpyridine) in India
Source: Export Import Data Bank, Department of Commerce (DGCI&S data), as published on 10 Nov 2026. The import bill is the total declared value, not a price per kg. How to read these figures.